Warning letter · FDA Warning Letters, Historical Archive

Nutrition Coalition Inc: FDA Warning Letter 566090 (Feb 5, 2019)

Agency action: Feb 5, 2019Record ID: fda_warning_-f11b8254b0b2168b
View official source ↗

What happened

Original notice title

Nutrition Coalition Inc MARCS-CMS 566090, February 05, 2019

From the archived source record

Hyman suggests a combination of supplements that improve the body’s glutathione-producing ability[, including] … Alpha lipoic acid … milk thistle … Vitamins B-6, B-12, and folate … Vitamins C and E … Selenium” “Vitamin D Could Reduce Mold Allergies” Support for Vitamin D’s Colorectal Cancer Prevention Abilities (reduced risk by 40%)” “Now, do you know which nutrient has been linked to preventing a variety of health problems including Cancers, Heart problems … Alzheimer’s …? Researchers concluded Curcumin … [i]s more effective at inhibiting the forming of protein fragments than many other potential Alzheimer’s treatments[, and that] Alzheimer’s symptoms caused by inflammation and oxidation are easy by curcumin’s powerful antioxidant and anti-inflammatory properties” “They also think Vitamin D may, like Curcumin, impact Alzheimer’s positively partly due to its anti-inflammatory … abilities.” “[P]eople who consume diets rich in B-12 may reduce their risk of Alzheimer’s in later years.” “Alpha Whey III Liquid Colostrum … [people] don’t ever seem to get colds any more. People with moderate deficiencies had an increased risk of 69% of developing Alzheimer’s, and those with a severe deficiency had their risk of developing Alzheimer’s increase by 122%. A drug is misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)] if the drug fails to bear adequate directions for its intended use(s). Accordingly, Alpha-Lipoid Acid, Colostrum Alpha Whey III (Liquid), Colloidal Silver, CoQ10, Curcumin, Echinacea Root, Liva-Vite, Milk Thistle, Selenium, Vinpocetine, Vitamin B Complex, Vitamin D3, and Vitamin E fail to bear adequate directions for their intended use and, therefore, the products are misbranded under section 502(f)(1) of the Act [21 U.S.C. § 352(f)(1)]. The introduction or delivery for introduction into interstate commerce of these misbranded drugs violates section 301(a) of the Act [21 U.S.C. § 331(a)].

What the official notice says to do

Check the original notice for the instructions that apply to the named product, company, and affected lots.

Read the official notice →

Status and source details

Status recorded in the archive
Historical warning letter; closeout not established by annual index
Source checked
Jul 16, 2026
Record revision
31da70c21df0

This is a dated record. Its current status may have changed since the source was captured. A record applies to its stated scope; it is not a safety rating for every product from a company.

Sources, dates, and coverage →

What is affected

Product
Colloidal Silver – 8oz; Echinacea Root – 60 Capsules; Liva-Vite -- 120 Tablets; Alpha-Lipoid Acid; Colostrum Alpha Whey III (Liquid); CoQ10; Curcumin; Liva-Vite; Milk Thistle; Selenium; Vinpocetine; Vitamin B Complex; Vitamin D3; and Vitamin E
Company
Nutrition Coalition Inc
Lot / identifier
The source does not specify this field.
Market / distribution
The source does not specify this field.